A doctor has warned those who breathe through their mouths during the day and at night that they are at risk of developing a ...

People who breathe through their mouths are more likely to suffer with problems including 'poor mouth breather face, sleep ...

WHEN doctors asked Curtis Arnold-Harmer how long he’d been using cocaine, the 29-year-old was baffled. “I’ve never touched the stuff,” he tells Sun Health. But surveying the trail of destruction ...

A selection of some of the most striking sports photographs taken around the world over the past seven days: Florian Schieder of Italy prepares at the start for the first Men's Downhill training ...

The Food and Drug Administration (FDA) has expanded its approval of a ketamine-derived nasal spray, Spravato (esketamine), as a standalone therapy for adults with treatment-resistant depression.

A pimple-like bump or sore inside the nose can sometimes be due to nasal vestibulitis or nasal folliculitis. It is a bacterial infection that can develop when hair follicles become infected ...

Roula Khalaf, Editor of the FT, selects her favourite stories in this weekly newsletter. Hundreds of thousands of displaced Palestinians moved north on Monday after Israeli forces withdrew from ...

Zicsaloma has announced that he has done a nose surgery as he shared the journey with his fans ... Fans took to the comment section to react after seeing his before and after pictures as they shared ...

The FDA has expanded its approval for a nasal spray as a standalone treatment for treatment-resistant depression. Getty Images The approval was granted following a study that showed Spravato was ...

This week, the Food and Drug Administration approved Johnson & Johnson’s ketamine-based nasal spray, Spravato, as a standalone therapy for cases of depression that haven’t responded to other ...

Johnson & Johnson has announced the FDA’s approval of a first-of-its-kind, esketamine nasal spray called Spravato for the standalone treatment of major depressive disorder (MDD), PTSD ...